FIELD: medicine, pharmaceutics.
SUBSTANCE: invention relates to field of veterinary, in particular to veterinary surgery, and can be applied in treatment of purulent wounds in animals. Medication for treatment of purulent wounds in animals includes active substance and ointment base - polyethylene oxide-1500 and polyethyl oxide-400. Active substance is a product of dry sublimation of birch chaga mushroom, mixed with polyethylene oxide-400 and polyethyleneoxide-1500 in ratio 1.25:4:1 respectively at temperature 39…4°C.
EFFECT: application of claimed medication for treatment of purulent wounds in animals will make it possible to increase efficiency of treatment of purulent skin-muscular wounds, with reduction of financial expenditures and terms of wound healing in animals.
1 tbl
| Title | Year | Author | Number |
|---|---|---|---|
| PREPARATION FOR TREATING ANIMAL SKIN DISEASES | 2013 |
|
RU2535127C1 |
| OINTMENT PREPARATION METHOD FOR TREATING SKIN DISEASES OF ANIMALS | 2019 |
|
RU2701161C1 |
| MEDICINAL PRODUCT FOR TREATMENT OF SKIN DISEASES OF ANIMALS | 2022 |
|
RU2798579C1 |
| MEDICINAL AGENT SHOWING REGENERATING AND WOUND-HEALING ACTION | 2000 |
|
RU2191574C2 |
| COMPOSITION FOR WOUND AND BURN TREATMENT | 1999 |
|
RU2164133C2 |
| OINTMENT MESH ATRAUMATIC BANDAGE | 2022 |
|
RU2784202C1 |
| COMPOSITION FOR SEPTIC WOUND REPAIR | 2006 |
|
RU2348396C2 |
| LOCAL PHARMACEUTICAL ANTIBACTERIAL COMPOSITION OF ACTIVE BIOMETALLIC COMPLEXES | 2011 |
|
RU2489147C2 |
| ANTIBACTERIAL AND NECROLYTIC LOCAL LISOAMIDASE PHARMACEUTICAL COMPOSITION | 2007 |
|
RU2367469C2 |
| OINTMENT FOR PURULENT WOUNDS TREATMENT | 1991 |
|
RU2008911C1 |
